Cancer Mythbusters Episode #5: Cancer Clinical Trials

episode

Understanding Cancer | Dana-Farber Cancer Institute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 9AM EDT 5 min · 24 Sep 2026 · NPR News Now

9AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

The Critic Who Finally Came Around | Jeanine Pt. 5 6 min · 24 Sep 2026 · The Best 5 Minute Wine Podcast

Ambitious But Lazy? Use This CIA Trick to Beat 99% of People 19 min · 24 Sep 2026 · EverydaySpy Podcast

Postpartum Fitness & My Boob Job… 1h 15m · 24 Sep 2026 · Pursuit of Wellness

326. Rethinks: The Secrets to Getting the Information You Need from AI 28 min · 24 Sep 2026 · Think Fast Talk Smart: Communication Techniques

Report any issue

Source

Recorded11 Dec 2017

Publisherfeeds.soundcloud.com ↗

Handlerec:4209916

Show notes

Clinical trials are scientific studies in which new treatments — drugs, diagnostic procedures, and other therapies — are tested to determine if they are safe and effective for patients. Nearly all cancer drugs in use today were tested and made available to patients through clinical trials, making them a crucial component of cancer research. But what does it mean for a patient to enroll in a clinical trial? In this episode of Cancer Mythbusters, we break down common myths and questions about how these trials work with the help of Geoffrey Shapiro, MD, PhD, director of the Early Drug Development Center at Dana-Farber.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in